Daily Derm Times: April 17, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Expert Insights From AAD 2025

From our April issue: Unlock exclusive AAD 2025 insights from top dermatology experts—what you missed and what’s next.

32.5% Decrease in Basal Cell Carcinoma Surgeries Reported Due to COVID-19 Pandemic

Additionally, BCC surgery candidates have been older with more comorbidities since the pandemic began.

Larry Eichenfield, MD: Icotrokinra Demonstrates Promising Results for Adolescents With Moderate to Severe Plaque Psoriasis

Eichenfield discusses high skin clearance and safety in teens with psoriasis, per new ICONIC-LEAD phase 3 data.

Screening for BDD Crucial in Aesthetic Dermatology

Patients undergoing plastic surgery have the highest prevalence of BDD at 24%.

How Anastasia Georgievskaya and SkinGPT Are Addressing Gaps in the Dermatology Industry

Haut.AI’s new tool promotes inclusive and realistic conversations on the power of skincare products, according to the CEO.

Hope on the Horizon: FDA to Weigh in on Dupilumab for CSU

Having multiple therapeutic options would allow clinicians to tailor treatment and offer hope to patients who don't respond initially.

Channel Therapeutics and Pelthos Therapeutics to Merge to Accelerate Launch of Zelsuvmi for Molluscum Contagiosum

Pelthos and Channel Therapeutics will merge to form a new publicly traded entity focused on commercializing the first at-home treatment for molluscum.